Cleviprex Injectable Emulsion
Chiesi USA is recalling Cleviprex (clevidipine injectable emulsion) 50 mg/100 mL vials due to a lack of assurance of sterility.
Healthcare providers should immediately examine their inventory, quarantine any affected product, and contact the manufacturer for return instructions.
Why it was recalled
Chiesi USA is recalling Cleviprex (clevidipine injectable emulsion) due to a lack of assurance of sterility. The affected product is supplied in 50 mg/100 mL (0.5 mg/mL) single-use vials.
Is mine affected?
Check the NDC or UPC and strength printed on the package. Yours is affected if it matches one below.
CLEVIPREX (clevidipine injectable emulsion) 50 mg/100 mL (0.5 mg/mL), 10 Single Use Vials, Rx Only, Manufactured for: Chiesi USA, Inc., Cary, NC 27518, by Fresenius Kabi, Graz, Austria, NDC 10122-611-10.
- Recall #
- D-0689-2026
Where it was sold
Distributed nationwide.
Official source
Other recent recalls from Chiesi USA, Inc.
Editorial summary by Recall Canary · last updated 2026-07-15 · primary source: U.S. Food and Drug Administration · severity reflects the agency's published classification